Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) Short Interest Update

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) was the target of a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 7,500 shares, a decrease of 38.5% from the December 31st total of 12,200 shares. Based on an average daily volume of 9,600 shares, the short-interest ratio is currently 0.8 days.

Clinuvel Pharmaceuticals Stock Performance

Shares of OTCMKTS CLVLY remained flat at $7.65 during mid-day trading on Friday. 41 shares of the stock traded hands, compared to its average volume of 3,206. The business has a 50-day moving average of $7.77 and a 200-day moving average of $8.90. Clinuvel Pharmaceuticals has a 52-week low of $6.80 and a 52-week high of $11.40.

About Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).